Rous sarcoma virus (RSV) is the only known replicationcompetent retrovirus to have naturally acquired an oncogene (v-src) (5, (12) (13) (14) . Heterologous sequences can be expressed instead of the v-src gene in RSV-based replication-competent retroviral (RCR) vectors (3, 7, 8, 10, 11) , whereby high-titer vector stocks can be generated simply by transfecting cells and allowing the vector to spread, without the need for the multiple transfection and/or selection protocols required for the production of replication-defective retroviral vectors. In addition to the use of RSV-based RCR vectors as tools in avian systems, RSV-based RCR vectors can be genetically pseudotyped with the amphotropic 4070A env gene from murine leukemia virus (MLV) to allow transgene delivery to mammalian cells (1, 2) . Since RSV does not replicate in mammalian cells, genetic pseudotyping of RSV-based RCR vectors also provides an interesting alternative to replicationdeficient MLV and human immunodeficiency virus vectors for human gene therapy (6) .
The modification of retroviral genomes by the addition of heterologous sequences, however, can lead to impaired replication kinetics, and due to the inherent propensity of retroviral genomes to undergo recombinations during reverse transcription, viral mutants lacking heterologous sequences will emerge as predominant subpopulations if they replicate with kinetics superior to those of the parental genotype. Such mutants may arise from RSV-based RCR vectors during vector production in avian cell culture or during replication in avian species in vivo. Hence, vector designs which allow rapid replication are desirable, since these should lead to more reliable transgene expression in target cells. We have therefore investigated the replication and transgene propagation kinetics of RSV-based RCR vectors utilizing different strategies to facilitate marker gene expression and have characterized the nucleotide sequences and/or structural motifs associated with the generation of predominant mutants arising during vector replication.
RCR vectors expressing fluorescent marker proteins were generated by modifying the genetically pseudotyped amphotropic vector RCASBPM2C(4070A) (1), whereby the expression of enhanced green fluorescent protein (eGFP) and Discosoma sp. red fluorescent protein (DsRed) from vectors RC ASBPM2C(4070A)eGFP and RCASBPM2C(4070A)DsRed or RCANBPM2C(4070A)IRESeGFP and RCANBPM2C (4070A)IRESDsRed was mediated either by an additional spliced message facilitated by the v-src splice acceptor (SA) or by an encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) (9) in the 3Ј untranslated region (UTR), respectively (Fig. 1A) .
To evaluate transgene propagation kinetics, vectors were used to inoculate DF-1 cells at a relative multiplicity of infection (MOI) of 0.001, calculated by comparing the reverse transcriptase (RT) activity of each vector preparation (determined using a product-enhanced RT [PERT] assay) to that of a stock of vector RCASBPM2C(4070A)eGFP of known titer. Following passaging and fluorescence-activated cell sorter (FACS) analyses every 2 or 3 days postinfection, it became apparent that vectors RCANBPM2C(4070A)IRESeGFP and RCANBPM2C(4070A)IRESDsRed propagated the eGFP and DsRed genes in infected cells much more efficiently than vectors RCASBPM2C(4070A)eGFP and RCASBPM2C(4070A) DsRed (Fig. 2A) . The relatively slow transgene propagation kinetics of vectors RCASBPM2C(4070A)eGFP and RCASBP M2C(4070A)DsRed suggested that the utilization of the v-src SA to facilitate transgene expression may interfere with virus replication. To investigate this hypothesis, PERT analyses were performed every 2 or 3 days following the infection of DF-1 cells at an MOI of 0.001. Additionally, to determine the impact of the v-src SA per se, vector RCASBPM2C(4070A) was compared with vector RCASBPM2C(4070A)delSA, in which the v-src SA is deleted (Fig. 1A) . PERT assay data revealed that vectors harboring either the eGFP or DsRed gene indeed replicated much more efficiently when the transgene was expressed via the EMCV IRES in the 3Ј UTR than when it was expressed from a spliced message facilitated by the v-src SA (Fig. 2B) . Interestingly, however, there was no difference in the replication kinetics of vectors RCASBPM2C (4070A) and RCASBPM2C(4070A)delSA, indicating that the presence of the v-src SA per se is not detrimental to virus replication (Fig. 2B) .
To evaluate the genomic stability of transgene-expressing (Fig. 1B) . This process was repeated for a total of 10 serial infection cycles. Even with the greatly reduced initial MOI and greatly increased dilution factor used in infection cycles with vectors RCANBPM2C(4070A)IRESeGFP and RCANBPM2C(4070A) IRESDsRed (MOI, 0.001; dilution, 1000-fold) compared to those used with vector RCASBPM2C(4070A)eGFP (MOI, 0.1; dilution, 10-fold), the former were able to propagate transgene expression over more infection cycles than the latter (Fig. 2C) .
To characterize predominant deletion mutants arising during vector replication, PCR was carried out using genomic DNA extracted from DF-1 cells infected with both transgeneexpressing and non-transgene-expressing vectors at an intial MOI of 0.001. PCR was also performed with DNA extracted from cells infected with vectors RCANBPM2C(4070A)IRESe GFP and RCANBPM2C(4070A)IRESDsRed following multiple serial 1,000-fold-diluting infection cycles. Analyses of PCR products from DNA extracted from cells infected with vectors RCANBPM2C(4070A)IRESeGFP and RCANBPM2C(4070A) IRESDsRed from infection cycles 2, 4, 6, 8, and 10 revealed that major deletion mutants did not emerge within the first two infection cycles (Fig. 3A and B, lanes 1) , becoming evident only during subsequent infection cycles (Fig. 3A and B, lanes 2 through 5). Analyses of PCR products from DNA extracted from four independent infection experiments with vectors RC ASBPM2C(4070A)eGFP and RCASBPM2C(4070A)DsRed, on the other hand, revealed that major deletion mutants became dominant in the vector population within a single infection cycle (Fig. 3C, lanes 1 to 4 and 5 to 8, respectively) . Thus, PCR results indicate that vectors from which transgene expression is mediated by an EMCV IRES in the 3Ј UTR are genomically much more stable than vectors from which transgene expression is mediated by a spliced message facilitated by the v-src SA. PCR analysis of DNA extracted from DF-1 cells infected with vectors RCASBPM2C(4070A) (Fig. 3D, lanes 1  and 2) and RCASBPM2C(4070A)delSA (Fig. 3D, lanes 3 and  4) gave rise to a single band of a size expected for the respective parental vectors, indicating that mutants did not emerge during the replication of these vectors.
Sequencing analyses of PCR products revealed that several common recombination junctions were involved in the formation of deletion mutants, both in different mutants of the same vector and in deletion mutants of different vectors, indicating that, at least to a certain extent, recombinogenic hot spots exist in the vectors evaluated in this study (see the supplemental material). Eight of the sequenced recombination junctions were associated with direct repeats and two were associated with inverted repeats, but over half of the sequenced recombination junctions revealed no role for nucleotide homology (see the supplemental material). No differences in the nucleotide sequences associated with IRES-or v-src-containing vectors could be ascertained. Strikingly, however, the v-src SA was deleted from almost every sequenced recombinant of vectors RCASBPM2C(4070A)eGFP and RCASBPM2C(4070A)DsRed, but not from the parental vector RCASBPM2C(4070A) (see the supplemental material), supporting the hypothesis that the presence of the v-src SA is not detrimental to RSV replication per se but only in combination with the presence of downstream transgenic sequences. It is possible that the use of an additional SA to facilitate the production of an additional subgenomic message for transgene expression leads to a concomitant decrease in the genomic length and the amount of env-spliced RNA in infected cells, which may, in turn, lead to a decrease in the amount of infectious virus particles being released, thus conferring the observed replicative disadvantage on vectors containing an additional SA. To investigate this hypothesis, Northern analyses were performed using RNA extracted from DF-1 cells infected with vectors (i) RCANBPM2C(4070A)IRESeGFP and RCAS BPM2C(4070A)eGFP at infection cycle 1 and (ii) RCASBP M2C(4070A)eGFP at infection cycles 1 and 10. At infection cycle 1, DF-1 cells infected with vector RCANBPM2C(4070A) IRESeGFP contained more env-spliced and full-length RNA than DF-1 cells infected with vector RCASBPM2C(4070A) eGFP, which contained large amounts of eGFP gene-spliced RNA and only poorly detectable full-length or env-spliced messages (Fig. 4, lanes 1 and 2, respectively) . In DF-1 cells infected with vector RCASBPM2C(4070A)eGFP at cycle 10, however, full-length and env-spliced messages were more abundant than those in DF-1 cells infected with vector RCAS BPM2C(4070A)eGFP at cycle 1 (Fig. 4, lane 4 and 3, respectively) . Hence, the results of the Northern analyses of RNA extracted from infected cells support the hypothesis that the use of an additional SA to facilitate the production of an additional subgenomic message for transgene expression leads to a decrease in the genomic length and the amount of envspliced RNA in infected cells and that vector mutants which contain deletions spanning the v-src SA no longer generate this subgenomic message, such that more full-length and envspliced messages are available for virus production, in turn leading to an increase in vector replication kinetics. In this respect, the observation that vector RCASBPM2C(4070A), which contains the v-src SA but does not replicate more slowly than vector RCASBPM2C(4070A), from which the SA is deleted, may be explained by the absence of additional downstream transgene sequences containing putative exonic splicing enhancers, which are known to play an important role in determining the level of splicing to upstream SAs (4).
Taken together, our results indicate that genetically pseudotyped, amphotropic RSV-based RCR vectors which utilize an EMCV IRES in the 3Ј UTR for transgene expression replicate more efficiently and are genomically more stable than equivalent vectors from which transgenes are expressed via a subgenomic message facilitated by the v-src SA and that, hence, predominant deletion mutants are less likely to arise during the generation of vector stocks by passaging in avian cells. Moreover, the findings we present here may be of relevance for RSV vectors in general and, thus, may also have implications for the use of replicating RSV vectors as research tools in avian systems, in which improved replication kinetics and vector stability represent a potentially significant advantage.
